Cargando…
Variations in MHC class I antigen presentation and immunopeptidome selection pathways
Major histocompatibility class I (MHC-I) proteins mediate immunosurveillance against pathogens and cancers by presenting antigenic or mutated peptides to antigen receptors of CD8+ T cells and by engaging receptors of natural killer (NK) cells. In humans, MHC-I molecules are highly polymorphic. MHC-I...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525337/ https://www.ncbi.nlm.nih.gov/pubmed/33014341 http://dx.doi.org/10.12688/f1000research.26935.1 |
_version_ | 1783588725879472128 |
---|---|
author | Zaitouna, Anita J. Kaur, Amanpreet Raghavan, Malini |
author_facet | Zaitouna, Anita J. Kaur, Amanpreet Raghavan, Malini |
author_sort | Zaitouna, Anita J. |
collection | PubMed |
description | Major histocompatibility class I (MHC-I) proteins mediate immunosurveillance against pathogens and cancers by presenting antigenic or mutated peptides to antigen receptors of CD8+ T cells and by engaging receptors of natural killer (NK) cells. In humans, MHC-I molecules are highly polymorphic. MHC-I variations permit the display of thousands of distinct peptides at the cell surface. Recent mass spectrometric studies have revealed unique and shared characteristics of the peptidomes of individual MHC-I variants. The cell surface expression of MHC-I–peptide complexes requires the functions of many intracellular assembly factors, including the transporter associated with antigen presentation (TAP), tapasin, calreticulin, ERp57, TAP-binding protein related (TAPBPR), endoplasmic reticulum aminopeptidases (ERAPs), and the proteasomes. Recent studies provide important insights into the structural features of these factors that govern MHC-I assembly as well as the mechanisms underlying peptide exchange. Conformational sensing of MHC-I molecules mediates the quality control of intracellular MHC-I assembly and contributes to immune recognition by CD8 at the cell surface. Recent studies also show that several MHC-I variants can follow unconventional assembly routes to the cell surface, conferring selective immune advantages that can be exploited for immunotherapy. |
format | Online Article Text |
id | pubmed-7525337 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | F1000 Research Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-75253372020-10-01 Variations in MHC class I antigen presentation and immunopeptidome selection pathways Zaitouna, Anita J. Kaur, Amanpreet Raghavan, Malini F1000Res Review Major histocompatibility class I (MHC-I) proteins mediate immunosurveillance against pathogens and cancers by presenting antigenic or mutated peptides to antigen receptors of CD8+ T cells and by engaging receptors of natural killer (NK) cells. In humans, MHC-I molecules are highly polymorphic. MHC-I variations permit the display of thousands of distinct peptides at the cell surface. Recent mass spectrometric studies have revealed unique and shared characteristics of the peptidomes of individual MHC-I variants. The cell surface expression of MHC-I–peptide complexes requires the functions of many intracellular assembly factors, including the transporter associated with antigen presentation (TAP), tapasin, calreticulin, ERp57, TAP-binding protein related (TAPBPR), endoplasmic reticulum aminopeptidases (ERAPs), and the proteasomes. Recent studies provide important insights into the structural features of these factors that govern MHC-I assembly as well as the mechanisms underlying peptide exchange. Conformational sensing of MHC-I molecules mediates the quality control of intracellular MHC-I assembly and contributes to immune recognition by CD8 at the cell surface. Recent studies also show that several MHC-I variants can follow unconventional assembly routes to the cell surface, conferring selective immune advantages that can be exploited for immunotherapy. F1000 Research Limited 2020-09-28 /pmc/articles/PMC7525337/ /pubmed/33014341 http://dx.doi.org/10.12688/f1000research.26935.1 Text en Copyright: © 2020 Zaitouna AJ et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Zaitouna, Anita J. Kaur, Amanpreet Raghavan, Malini Variations in MHC class I antigen presentation and immunopeptidome selection pathways |
title | Variations in MHC class I antigen presentation and immunopeptidome selection pathways |
title_full | Variations in MHC class I antigen presentation and immunopeptidome selection pathways |
title_fullStr | Variations in MHC class I antigen presentation and immunopeptidome selection pathways |
title_full_unstemmed | Variations in MHC class I antigen presentation and immunopeptidome selection pathways |
title_short | Variations in MHC class I antigen presentation and immunopeptidome selection pathways |
title_sort | variations in mhc class i antigen presentation and immunopeptidome selection pathways |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525337/ https://www.ncbi.nlm.nih.gov/pubmed/33014341 http://dx.doi.org/10.12688/f1000research.26935.1 |
work_keys_str_mv | AT zaitounaanitaj variationsinmhcclassiantigenpresentationandimmunopeptidomeselectionpathways AT kauramanpreet variationsinmhcclassiantigenpresentationandimmunopeptidomeselectionpathways AT raghavanmalini variationsinmhcclassiantigenpresentationandimmunopeptidomeselectionpathways |